This kit is used for in vitro qualitative detection of novel coronavirus (SARS-CoV-2) IgM antibodies in human serum samples. It is used in conjunction with nucleic acid detection and cannot be used as a basis for the diagnosis and elimination of novel coronavirus pneumonia. It cannot be used for general population screening.
Characteristics
Specification
12 tests/kit
Instrument
Full-Automatic Chemiluminescence Immunoassay System (FACIS-I)
Stability
The kit is stable for 1 year at 2-8°C
Advantage
All in one
Integrated reagents and consumables together, more convenient
Unique sample pretreatment system
Using micron film with invention patent for sample pretreatment, easy to operate
Automatic
Fully automatically perform experiment process & date analysis